logo

For the Inventor, By the Inventor

Moscow, Russia

Evgeny Antonovich Lukiyanets

This inventor holds 1 USPTO granted patent. Top assignees: Gosudarsvenny Nauchy Tsentr Rossiiskoi Federatsii 'Niopik', Institut Elementoorganicheskikh Soedineny Rossiiskoi Akademii Nauk, Moskovsky Naucho-Issledovatelsky Onkologichesky Institut. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Evgeny Antonovich Lukiyanets. Retrieved from https://idiyas.com/inventor/evgeny-antonovich-lukiyanets

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:

goldMedal1 out of 1 
 
Gosudarsvenny Nauchy Tsentr Rossiiskoi Federatsii 'Niopik'
 patent
silverMedal1 out of 1 
 
Institut Elementoorganicheskikh Soedineny Rossiiskoi Akademii Nauk
 patent
bronzeMedal1 out of 1 
 
Moskovsky Naucho-Issledovatelsky Onkologichesky Institut
 patent
4. 1 out of 1 
 
Onkologichesky Nauchy Tsentr Rossiiskoi Akademii Nauk
 patent
where one patent can have more than one assignee

Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents
1. 6004953 - Agent for suppressing tumor growth (1999-12-21),

Title: Profile of Inventor Evgeny Antonovich Lukiyanets

Introduction: Evgeny Antonovich Lukiyanets is a distinguished inventor based in Moscow, Russia. He has made significant contributions to the field of medicine, particularly with his innovative approach to cancer treatment. His work has garnered attention and recognition in the scientific community.

Latest Patents: Lukiyanets holds a patent for an "Agent for Suppressing Tumor Growth." This invention highlights his commitment to advancing medical treatments and improving patient outcomes in oncology.

Career Highlights: Throughout his career, Evgeny has been associated with prominent research institutions, including the Institute of Elemento-organic Compounds of the Russian Academy of Sciences and the State Scientific Center of the Russian Federation 'NIOPIK'. These roles have enabled him to contribute to groundbreaking research and innovation.

Collaborations: Lukiyanets has collaborated with esteemed colleagues such as Mark Efimovich Volpin, who is now deceased, and Georgy Nikolaevich Vorozhtsov. Their combined expertise has likely fostered valuable insights and advancements in their research efforts.

Conclusion: Evgeny Antonovich Lukiyanets exemplifies the spirit of innovation through his work in the field of cancer treatment. His patent for an agent that suppresses tumor growth is a testament to his dedication to improving healthcare and addressing critical medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…